跳至主要内容
临床试验/ISRCTN28592111
ISRCTN28592111已完成未知

The effect of glycopyrronium bromide on hypersalivation in patients with Parkinson's disease: a randomised, cross-over, double blind, placebo-controlled trial

Hospital Medisch Spectrum Twente (The Netherlands)0 个研究点目标入组 23 人开始时间: 2007年2月8日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
23

研究概览

简要总结

2010 results in https://pubmed.ncbi.nlm.nih.gov/20385892/ (added 15/01/2021)

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients with Parkinson's disease
  • 2. Aged more than or equal to 18 years
  • 3. Hypersalivation score more than or equal to five (on a scale from one to nine)
  • 4. Patient or family is able to score the extent of hypersalivation

排除标准

  • 1. Hypersensitivity to glycopyrronium bromide, sorbic acid or saccharin sodium
  • 2. Myasthenia gravis
  • 3. Symptomatic tachycardia
  • 4. Coronary insufficiency
  • 5. Heart rhythm disorders
  • 6. Glaucoma
  • 7. Pylorus stenosis
  • 8. Paralytic ileus
  • 9. Prostate hypertrophy
  • 10 Patients using potassium chloride tablets, oral digoxin or oral corticosteroids
  • 11. Kidney function disorders
  • 12. Pregnancy or lactation

研究者

发起方
Hospital Medisch Spectrum Twente (The Netherlands)

相似试验